RE: Comment14 Apr 2019 13:41
What’s to stop them having an editorial feature in the Sunday Times for instance regarding the letter of intent for the 401 compound, giving them opportunity to mention there other compounds that are looking very promising.
Create a buzz around their company, with extremely positive results so far, bla,bla,bla
After all it is cancer, a very important subject with everyone.
My apologies in advance if I have missed anything like this. It’s already been included in an RNS, so publicly mentioned.
Sent